SEARCH

SEARCH BY CITATION

References

  • 1
    Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
  • 2
    Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9-29.
  • 3
    Humphrey LL, Deffebach M, Pappas M, et al. Screening for lung cancer with low-dose computed tomography: a systematic review to update the U.S. Preventive Services Task Force recommendation. Ann Intern Med. 2013;159:411-420.
  • 4
    Moyer VA. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160:330-338.
  • 5
    Tabar L, Vitak B, Chen TH, et al. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology. 2011;260:658-663.
  • 6
    Shaukat A, Mongin SJ, Geisser MS, et al. Long-term mortality after screening for colorectal cancer. N Engl J Med. 2013;369:1106-1114.
  • 7
    Smith RA, Manassaram-Baptiste D, Brooks D, et al. Cancer screening in the United States, 2014: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2014;64:30-51.
  • 8
    Aberle D, Adams A, Berg C, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365:395-409.
  • 9
    Wood D, Eapen G, Ettinger D, et al. Lung cancer screening. J Natl Compr Cancer Netw. 2012;10:240-265.
  • 10
    Jacobson F, Austin JH, Field J, et al. Development of the American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of the American Association for Thoracic Surgery Task Force for Lung Cancer Screening and Surveillance. J Thorac Cardiovasc Surg. 2012;144:25-32.
  • 11
    Jaklitsch M, Jacobson F, Austin JH, et al. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg. 2012;144:33-38.
  • 12
    American Lung Association. Providing Guidance for Lung Cancer Screening: The American Lung Association Interim Report on Lung Cancer Screening. lung.org/lung-disease/lung-cancer/lung-cancer-screening-guidelines/. Accessed June 5, 2014.
  • 13
    Infante M, Cavuto S, Lutman FR, et al; DANTE Study Group. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med. 2009;180:445-453.
  • 14
    Saghir Z, Dirksen A, Ashraf H, et al. CT screening for lung cancer brings forward early disease. The randomised Danish lung cancer screening trial: status after five annual screening rounds with low-dose CT. Thorax. 2012;67:296-301.
  • 15
    Pastorino U, Rossi M, Rosato V, et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev. 2012;3:308-315.
  • 16
    Pedersen JH, Ashraf H, Dirksen A, et al. The Danish randomized lung cancer CT screening trial–overall design and results of the prevalence round. J Thorac Oncol. 2009;4:608-614.
  • 17
    van Klaveren R, Oudkerk M, Prokop M, et al. Management of lung nodules detected by volume CT scanning. N Engl J Med. 2009;361:2221-2229.
  • 18
    Aberle DR, DeMello S, Berg CD, et al; National Lung Screening Trial Research Team. Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med. 2013;369:920-931.
  • 19
    Tammemagi MC, Katki HA, Hocking WG, et al. Selection criteria for lung-cancer screening. N Engl J Med. 2013;368:728-736.
  • 20
    Paul S, Altorki N, Sheng S, et al. Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database. J Thorac Cardiovasc Surg. 2010;139:366-378.
  • 21
    Lung Cancer Alliance. Rights and Expectations for Excellence in Lung Cancer Screening and Continuum of Care. lungcanceralliance.org/get-information/am-i-at-risk/national-framework-for-lung-screening-excellence.html. Accessed June 5, 2014.
  • 22
    Henschke CI. Definition of a positive test result in computed tomography screening for lung cancer: a cohort study. Ann Intern Med. 2013;158:246-252.
  • 23
    Goldstraw P, Crowley J, Chansky K, et al; International Association for the Study of Lung Cancer International Staging Committee and Participating Institutions. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours. J Thorac Oncol. 2007;2:706-714.
  • 24
    Flores R, Park B, Dycoco J, et al. Lobectomy by video-assisted thoracic surgery (VATS) versus thoracotomy for lung cancer. J Thorac Cardiovasc Surg. 2009;138:11-18.
  • 25
    Bach P, Mirkin J, Oliver T, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA. 2012;307:2418-2429.
  • 26
    Humphrey L, Deffebach M, Pappas M, et al. Screening for Lung Cancer: Systematic Review to Update the U.S. Preventive Services Task Force Recommendation. Report No. 13-05188-EF-1. Rockville, MD: Agency for Healthcare Research and Quality; 2013.
  • 27
    Swensen SJ, Jett JR, Sloan JA, et al. Screening for lung cancer with low-dose spiral computed tomography. Am J Respir Crit Care Med. 2002;165:508-513.
  • 28
    Wagnetz U, Menezes R, Boerner S, et al. CT screening for lung cancer: implication of lung biopsy recommendations. AJR Am J Roentgenol. 2012;198:351-358.
  • 29
    Yankelevitz DF, Reeves AP, Kostis WJ, Zhao B, Henschke CI. Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation. Radiology. 2000;217:251-256.
  • 30
    US Preventive Services Task Force. Grade Definitions. uspreventiveservicestaskforce.org/uspstf/grades.htm. Accessed June 5, 2014.
  • 31
    Marcus PM, Bergstralh EJ, Zweig MH, Harris A, Offord KP, Fontana RS. Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis. J Natl Cancer Inst. 2006;98:748-756.
  • 32
    Strauss G, Dominioni L. Varese meeting report. Lung Cancer. 1999;23:171-172.
  • 33
    Humphrey LL, Teutsch S, Johnson M; U.S. Preventive Services Task Force. Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2004;140:740-753.
  • 34
    Raz D, Zell J, Ou SI, Gandara D, Anton Culver H, Jablons D. Natural history of stage I non-small cell lung cancer: implications for early detection. Chest. 2007;132:193-199.
  • 35
    Wender R, Fontham ET, Barrera E Jr, et al. American Cancer Society lung cancer screening guidelines. CA Cancer J Clin. 2013;63:106-117.
  • 36
    Frank L, Christodoulou E, Kazerooni EA. Radiation risk of lung cancer screening. Semin Respir Crit Care Med. 2013;34:738-747.
  • 37
    American Association of Physicists in Medicine. AAPM Position Statement on Radiation Risks from Medical Imaging Procedures. aapm.org/org/policies/details.asp?id=318&type=PP&current=true. Accessed June 5, 2014.
  • 38
    American College of Radiology. ACR Lung Cancer Screening Center. acr.org/Quality-Safety/Lung-Cancer-Screening-Center. Accessed June 5, 2014.
  • 39
    National Comprehensive Cancer Network. NCCN Guidelines for Patients. Lung Cancer Screening. nccn.org/patients/guidelines/lung_screening/index.html. Accessed June 5, 2014.
  • 40
    Altorki NK, Yip R, Hanaoka T, et al; I-ELCAP Investigators. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules. J Thorac Cardiovasc Surg. 2014;147:754-762; discussion 762-764.
  • 41
    Borgmeyer C. Evidence Lacking to Support or Oppose Low-Dose CT Screening for Lung Cancer, says AAFP. Inability to Make Harms/Benefits Comparison Precludes Definitive Recommendation. aafp.org/news/health-of-the-public/20140113aafplungcarec.html. Accessed June 5, 2014.
  • 42
    Van't Westeinde SC, Horeweg N, De Leyn P, et al. Complications following lung surgery in the Dutch-Belgian randomized lung cancer screening trial. Eur J Cardiothorac Surg. 2012;42:420-429.
  • 43
    Mulshine JL, Altorki N. Implementing lung cancer screening: a checklist. Lung Cancer Manag. 2014;3:1-4.
  • 44
    Villanti AC, Jiang Y, Abrams DB, Pyenson BS. A cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions. PLoS One. 2013;8:e71379.
  • 45
    Buckler AJ, Mulshine JL, Gottlieb R, Zhao B, Mozley PD, Schwartz L. The use of volumetric CT as an imaging biomarker in lung cancer. Acad Radiol. 2010;17:100-106.
  • 46
    Bach PB. Raising the bar for the U.S. Preventive Services Task Force. Ann Intern Med. 2014;160:365-366.
  • 47
    van Klaveren RJ, de Koning HJ, Mulshine J, Hirsch FR. Lung cancer screening by spiral CT. What is the optimal target population for screening trials? Lung Cancer. 2002;38:243-252.
  • 48
    Hoggart C, Brennan P, Tjonneland A, et al. A risk model for lung cancer incidence. Cancer Prev Res. 2012;5:834-846.
  • 49
    Raji O, Duffy S, Agbaje O, et al. Predictive accuracy of the Liverpool Lung Project risk model for stratifying patients for computed tomography screening for lung cancer: a case-control and cohort validation study. Ann Intern Med. 2012;157:242-250.
  • 50
    Vineis P, Alavanja M, Buffler P, et al. Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst. 2004;96:99-106.
  • 51
    Foy M, Yip R, Chen X, Kimmel M, Gorlova O, Henschke C. Modeling the mortality reduction due to computed tomography screening for lung cancer. Cancer. 2011;117:2703-2708.
  • 52
    Henschke CI, Boffetta P, Gorlova O, Yip R, Delancey JO, Foy M. Assessment of lung-cancer mortality reduction from CT screening. Lung Cancer. 2011;71:328-332.
  • 53
    Mulshine JL, Sullivan DC. Clinical practice. Lung cancer screening. N Engl J Med. 2005;352:2714-2720.
  • 54
    Ostroff JS, Buckshee N, Mancuso CA, Yankelevitz DF, Henschke CI. Smoking cessation following CT screening for early detection of lung cancer. Prev Med. 2001;33:613-621.
  • 55
    Field J, Smith R, Aberle D, et al; IASLC CT Screening Workshop 2011 Participants. International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report. J Thorac Oncol. 2012;7:10-19.
  • 56
    Slatore C, Baumann C, Pappas M, Humphrey LL. Smoking behaviors among patients receiving computed tomography for lung cancer screening: systematic review in support of the U.S. Preventive Services Task Force [published online ahead of print April 4, 2014]. Ann Am Thorac Soc.
  • 57
    Mulshine JL, Healton C. Tobacco control since the 1964 Surgeon General's Report: reflecting back and looking forward. Oncology. 2014;28:180-183.
  • 58
    Pyenson B, Sander M, Jiang Y, Kahn H, Mulshine J. An actuarial analysis shows that offering lung cancer screening as an insurance benefit would save lives at relatively low cost. Health Aff. 2012;31:770-779.
  • 59
    Centers for Medicare and Medicaid Services. Medicare Demonstration Projects and Evaluation Reports. cms.gov/Medicare/Demonstration-Projects/DemoProjectsEvalRpts/index.html. Accessed June 5, 2014.
  • 60
    Agaku IT, King BA, Dube SR, Centers for Disease Control and Prevention (CDC). Current cigarette smoking among adults-United States, 2005-2012. MMWR Morb Mortal Wkly Rep. 2014;63:29-34.
  • 61
    Mong C, Garon EB, Fuller C, et al. High prevalence of lung cancer in a surgical cohort of lung cancer patients a decade after smoking cessation. J Cardiothorac Surg. 2011;6:19.
  • 62
    Villines T, Taylor A. Multi-ethnic study of atherosclerosis arterial age versus Framingham 10-year or lifetime cardiovascular risk. Am J Cardiol. 2012;110:1627-1630.
  • 63
    Shemesh J, Henschke CI, Shaham D, et al. Ordinal scoring of coronary artery calcifications on low-dose CT scans of the chest is predictive of death from cardiovascular disease. Radiology. 2010;257:541-548.
  • 64
    Avila RS, Zulueta JJ, Shara NM, et al. A quantitative method for estimating individual lung cancer risk. Acad Radiol. 2010;17:830-840.
  • 65
    Zulueta J, Wisnivesky J, Henschke C, et al. Emphysema scores predict death from COPD and lung cancer. Chest. 2012;141:1216-1223.
  • 66
    US Burden of Disease Collaborators. The state of US health, 1990-2010: burden of diseases, injuries, and risk factors. JAMA. 2013;310:591-608.
  • 67
    McWilliams A. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med. 2013;369:910-919.
  • 68
    Rocco G, Allen MS, Altorki NK, et al. Clinical statement on the role of the surgeon and surgical issues relating to computed tomography screening programs for lung cancer. Ann Thorac Surg. 2013;96:357-360.
  • 69
    US Preventive Services Task Force. A and B Recommendations by Date. uspreventiveservicestaskforce.org/uspstf/uspsabrecs.htm. Accessed June 5, 2014.
  • 70
    Lung Cancer Alliance. Letter: National Coverage Analysis for Lung Cancer Screening With Low Dose Computed Tomography. lungcanceralliance.org/assets/docs/Leg%20Act/LCA%20ACR%20STS%20Consensus%20Letter%203_12_14.pdf. Accessed June 5, 2014.
  • 71
    Institute of Medicine (US) Roundtable on Value and Science-Driven Health Care. Clinical Data as the Basic Staple of Health Learning: Creating and Protecting a Public Good: Workshop Summary. Washington, DC: The National Academies Press; 2010.
  • 72
    Baird B. To improve public policy. Science. 2013;340:432-433.